affect

(redirected from Pseudobulbar affect)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Wikipedia.
Related to Pseudobulbar affect: Pseudobulbar palsy

affect

Psychol the emotion associated with an idea or set of ideas

Affect

 

an emotional state that is characterized by a turbulent and relatively short course (rage, anger, horror, and so forth). The manifestation of affect is linked with sharply expressed changes both in the autonomous motor sphere (inhibition or overexcitation and disorder in the coordination of movement) and in the sphere of vegetative reactions (change of pulse and breathing, spasms of the peripheral blood vessels, the appearance of so-called cold sweat, and so forth). Affect can disturb the normal course of the higher psychic processes of perception and thinking and can cause a decrease in consciousness or its loss. Under certain conditions, negative affect can be fixated in the memory in the form of so-called affective complexes. These traces of past affective states can become reactivated in the present under the influence of irritants associated with the situation that caused the affect. Another important peculiarity of affect is that with the repetition of a negative affect which is caused by the same factor or analogous factors, its manifestation can be reinforced (the phenomenon of “accumulation” of affect), sometimes creating the impression of pathological conduct. The presence of strong affective states in a person at the time when he commits an action is regarded by the law as a circumstance that decreases the degree of his responsibility for these actions.

A. N. LEONT’EV

affect

[′af‚ekt]
(psychology)
Conscious awareness of feelings; mood.
References in periodicals archive ?
Poster Presentation Details: Title: Dextromethorphan/Quinidine for Treatment of Pseudobulbar Affect in Patients With Dementia: Examination of CNS-LS Outcomes in a 12-Week Open-Label Trial (PRISM II) Poster Number: P3-290 Time: Tuesday, July 21, 9:30 a.
Dextromethorphan/Quinidine (DMQ) treatment significantly increased percentage of days free of pseudobulbar affect (PBA) episodes in a phase 3, randomized, placebo-controlled trial
NUEDEXTA remains the only FDA-approved product for the treatment of pseudobulbar affect.
295: PERSISTENT EFFICACY OF DEXTROMETHORPHAN (DM)/QUINIDINE (Q) FOR PSEUDOBULBAR AFFECT (PBA): RESULTS FROM A 12-WEEK, OPEN-LABEL EXTENSION (OLE) STUDY
Oral Presentation Details: Title: Dextromethorphan and Quinidine for Treatment of Pseudobulbar Affect (PBA): Time Course of PBA Episode Remission Abstract Number: S31.
Poster Presentation Details Title: Study of Pseudobulbar Affect Symptoms in Veterans with Mild Traumatic Brain Injury Abstract/Poster Number: 0742 (Poster Session 3) Presentation Date/Time: Friday, March 21, 9:30-10:30 a.
NASDAQ: AVNR) in collaboration with the Department of Veterans Affairs (VA) and United BioSource Corporation (UBC) today announced a pilot study to screen for pseudobulbar affect (PBA) symptoms in approximately 1,000 veterans with traumatic brain injury (TBI) .
Thankfully, Sonja was diagnosed with pseudobulbar affect (PBA) during therapy, as it was interfering with her ability to participate in the exercises.
This double-blind study evaluated two doses of the investigational drug Zenvia[TM] (dextromethorphan/quinidine) compared to placebo in the treatment of patients with pseudobulbar affect (PBA) secondary to ALS or multiple sclerosis (MS).
Jonathan Fellus' presentation entitled The PRISM Registry: A Novel Research Tool to Estimate the Prevalence of Pseudobulbar Affect highlighted data showing that of the 4,349 enrolled patients, approximately 37% of all participants had PBA symptoms as measured by a CNS-LS score eN13.